Documents
■Keynote Speech
■RA Session
- RA1_WHO Good Reliance Practices throughout the life cycle to facilitate access to quality-assured medical products globally
- RA2_Reliance Pathways in APAC：Current Adoption, Challenges, and Opportunities for Optimization
- RA3_Experience in Implementing Reliance Pathways for NDA and PAC
- RA4_Optimizing Reliance Pathways Across the Product Lifecycle Exploring Best Practices to Enhance Predictability and Consistency
■e-labeling Session
- EL2_E-labeling Pilot Project Update-Indonesia Case Study
- EL3_THE QUEST FOR INTEROPERABILITY：MALAYSIA’S STRATEGIC ROADMAP FROM PDF TO FHIR-READY XML
- EL4_E-Labeling in Taiwan：Implementation Status and Future Directions
- EL5_E-Labeling Current Status and Next Steps In Japan
- EL6_Enhancing access to innovative medicines for the people in Asia
■MQS Session
- MQS1_MQS Session Advanced Technologies (AT)
- MQS2_Opening&Introduction
- MQS3_Artificial Intelligence(AI)Machine Learning (ML) in Pharmaceutical Manufacturing
- MQS4_Application of Artificial Intelligence in Pharmaceutical Manufacturing
- MQS5_Implementation of Advanced Technologies in Pharmaceutical Manufacturing in Japan
